speb/financial-data huggingface dataset:
Financial ratios for JNJ — annual report dated 2025-12-31
Total revenue: 94193000000
Gross profit: 63937000000
Operating income: 25596000000
Net income: 26804000000
Capital expenditures: 4832000000
Operating cash flow: 24530000000
Depreciation & amortization: 7503000000
Net tangible assets: -17631000000
Owner earnings: 29475000000
Return on net tangible assets (%): -167.17713118938232
Capex to operating income (%): 18.877949679637442
Buffett classification: The Great
Stock price: 204.68
P/E ratio: 18.402404299132964
Shares outstanding: 2409898597
Book value: 81544000000
P/B ratio: 6.04898024175856
Market cap (USD): 493258044833.96
Debt to equity: 0.5878176199352497
Current ratio: 1.027676163027011
Quick ratio: 0.7654916306396187
Effective tax rate (%): 17.7311930266106
Interest coverage ratio: 26.360453141091657
COGS to revenue (%): 32.12128289787988
R&D to revenue (%): 15.56909749132101
SG&A to revenue (%): 25.1356257896022
Free cash flow (dilution-adjusted): 17959000000
Buyback yield (%): 1.2068733723347365
Inventory turnover: 2.1320555281516453
Receivables turnover: 4.4157798509211945
Capitalized R&D asset: 31188490000
ROCI (R&D-adjusted, %): 13.955855127100852
Rosenberg metric: 0.15012766945218198
FCF margin (%): 19.066172645525675
Revenue growth (%): 6.048119251078011
Rule of 40 score: 25.114291896603685
Financial ratios for LIV.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.00445945945945946
Shares outstanding: 165355421
Market cap (USD): 737395.7963513514
Buyback yield (%): 1110.0056680056139
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIV.L — annual report dated 2022-12-31
Total revenue: -25536144.578313254
Net income: -29351807.228915665
Capital expenditures: 0
Operating cash flow: 21430120.48192771
Depreciation & amortization: 122891.56626506025
Net tangible assets: 153885542.1686747
Owner earnings: -29228915.662650604
Return on net tangible assets (%): -18.993932276375027
Buffett classification: The Gruesome
Stock price: 0.003855421686746988
Shares outstanding: 165355421
Book value: 153885542.1686747
P/B ratio: 0.004142786041886866
Market cap (USD): 637514.8761445783
Debt to equity: 0.0006811509101585437
Free cash flow (dilution-adjusted): 21430120.48192771
Buyback yield (%): 0
Retained earnings: -17097590.361445785
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIV.L — annual report dated 2023-12-31
Total revenue: 22478481.012658227
Net income: 17579746.83544304
Capital expenditures: 0
Operating cash flow: 26111392.40506329
Depreciation & amortization: 124050.6329113924
Net tangible assets: 171945569.62025315
Owner earnings: 17703797.46835443
Return on net tangible assets (%): 10.29616378453588
Buffett classification: The Gruesome
Stock price: 0.0035443037974683548
P/E ratio: 0.03333778649193549
Shares outstanding: 165355421
Book value: 171945569.62025315
P/B ratio: 0.003408461456009777
Market cap (USD): 586069.8465822785
Debt to equity: 0
Effective tax rate (%): 1.636093207734259
COGS to revenue (%): 0
SG&A to revenue (%): 17.090888613582607
Free cash flow (dilution-adjusted): 26111392.40506329
Buyback yield (%): 0
Retained earnings: -6665822.784810126
Receivables turnover: 1109.875
Capitalized R&D asset: 0
FCF margin (%): 116.16172992454106
Rule of 40 score: 116.16172992454106
Financial ratios for LIV.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 173878750
Buffett classification: The Gruesome
Stock price: 0.005999999999999999
Shares outstanding: 165355421
Book value: 173878750
P/B ratio: 0.005705887154123203
Market cap (USD): 992132.5259999998
Debt to equity: 0.002990589706907831
Buyback yield (%): 0
Retained earnings: -7086250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIV.L — annual report dated 2024-12-31
Total revenue: 15495000
Net income: 8231250
Capital expenditures: 0
Operating cash flow: 21906250
Depreciation & amortization: 155000
Net tangible assets: 173878750
Owner earnings: 8386250
Return on net tangible assets (%): 4.823044794145345
Buffett classification: The Gruesome
Stock price: 0.005999999999999999
P/E ratio: 0.12053242533029611
Shares outstanding: 165355421
Book value: 173878750
P/B ratio: 0.005705887154123203
Market cap (USD): 992132.5259999998
Debt to equity: 0.002990589706907831
Effective tax rate (%): 2.933372641509434
COGS to revenue (%): 0
SG&A to revenue (%): 42.30396902226525
Free cash flow (dilution-adjusted): 21906250
Buyback yield (%): 0
Retained earnings: -7086250
Receivables turnover: 165.28
Capitalized R&D asset: 0
FCF margin (%): 141.37625040335593
Revenue growth (%): -31.067406239441375
Rule of 40 score: 110.30884416391456
Financial ratios for LIV.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 180793150.68493152
Buffett classification: The Gruesome
Stock price: 0.006712328767123288
Shares outstanding: 165355421
Book value: 180793150.68493152
P/B ratio: 0.006139170344524507
Market cap (USD): 1109919.9491780822
Debt to equity: 0.0031520166087029
Buyback yield (%): 0
Retained earnings: -19047945.205479454
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDCX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -11180902
Net income: -11155516
Capital expenditures: 0
Operating cash flow: -10247231
Net tangible assets: 3134704
Owner earnings: -11155516
Return on net tangible assets (%): -355.8714315610023
Buffett classification: The Gruesome
Stock price: 2.43
Shares outstanding: 56658164
Book value: 3134704
P/B ratio: 43.92100131942282
Market cap (USD): 137679338.52
Debt to equity: 0.10280651697895558
Current ratio: 2.3320784709584346
Quick ratio: 2.3320784709584346
Interest coverage ratio: -12.390705725640043
Free cash flow (dilution-adjusted): -10960350
Buyback yield (%): 0
Retained earnings: -28903903
Capitalized R&D asset: 3870789.98
ROCI (R&D-adjusted, %): -126.31365286821021
Rule of 40 score: 0
Financial ratios for MDCX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.43
Shares outstanding: 56658164
Market cap (USD): 137679338.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDCX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5126274
Net income: -5102408
Capital expenditures: 0
Operating cash flow: -3940994
Net tangible assets: 2147554
Owner earnings: -5102408
Return on net tangible assets (%): -237.5916042157729
Buffett classification: The Gruesome
Stock price: 3.72
Shares outstanding: 56658164
Book value: 2147554
P/B ratio: 98.1434553356982
Market cap (USD): 210768370.08
Debt to equity: 0.13722262629950166
Current ratio: 1.5251512703411207
Quick ratio: 1.5251512703411207
Free cash flow (dilution-adjusted): -4053271
Buyback yield (%): 0
Retained earnings: -34006311
Receivables turnover: 0
Capitalized R&D asset: 2006214
ROCI (R&D-adjusted, %): -87.53820614509844
Rule of 40 score: 0
Financial ratios for MDCX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -6016088
Net income: -6176084
Capital expenditures: 0
Operating cash flow: -5468831
Net tangible assets: 3248710
Owner earnings: -6176084
Return on net tangible assets (%): -190.10881242093015
Buffett classification: The Gruesome
Stock price: 2.99
Shares outstanding: 56658164
Book value: 3248710
P/B ratio: 52.1462089136919
Market cap (USD): 169407910.36
Debt to equity: 1.528654450535751
Current ratio: 1.2870457206760404
Quick ratio: 1.2870457206760404
Free cash flow (dilution-adjusted): -5586279
Buyback yield (%): 0
Retained earnings: -40182395
Capitalized R&D asset: 2783727.38
ROCI (R&D-adjusted, %): -92.72659756673501
Rule of 40 score: 0
Financial ratios for MDCX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -15426340
Net income: -15981312
Capital expenditures: 0
Operating cash flow: -6757829
Net tangible assets: -910126
Owner earnings: -15981312
Buffett classification: The Gruesome
Stock price: 2.32
Shares outstanding: 56658164
Book value: -804890
Market cap (USD): 131446940.47999999
Debt to equity: -8.76086421747071
Current ratio: 0.9177615742536922
Quick ratio: 0.9177615742536922
Free cash flow (dilution-adjusted): -7610586
Buyback yield (%): 0
Retained earnings: -56163630
Capitalized R&D asset: 12028816.5
ROCI (R&D-adjusted, %): -84.9454026238445
Rule of 40 score: 0
Financial ratios for MDCX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -34359302
Net income: -35444215
Capital expenditures: 0
Operating cash flow: -22776769
Net tangible assets: -67554
Owner earnings: -35444215
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 56658164
Book value: 37311
P/B ratio: 2323.362839913162
Market cap (USD): 86686990.92
Debt to equity: 146.79325131998607
Current ratio: 0.9952286471949964
Quick ratio: 0.9952286471949964
Free cash flow (dilution-adjusted): -24288963
Buyback yield (%): 0
Retained earnings: -64348118
Capitalized R&D asset: 18866408.36
ROCI (R&D-adjusted, %): -129.7569332609102
Rule of 40 score: 0
Financial ratios for MDCX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -7790600
Net income: -8184411
Capital expenditures: 0
Operating cash flow: -6609115
Net tangible assets: -67554
Owner earnings: -8184411
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 56658164
Book value: 37311
P/B ratio: 2323.362839913162
Market cap (USD): 86686990.92
Debt to equity: 146.79325131998607
Current ratio: 0.9952286471949964
Quick ratio: 0.9952286471949964
Free cash flow (dilution-adjusted): -7038827
Buyback yield (%): 0
Retained earnings: -64348118
Capitalized R&D asset: 10035443.979999999
ROCI (R&D-adjusted, %): -98.5418004276739
Rule of 40 score: 0
Financial ratios for MMLP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 39124686
Market cap (USD): 100941689.88000001
Buyback yield (%): 0.016841406182331292
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMLP — annual report dated 2022-12-31
Total revenue: 1018878000
Gross profit: 339292000
Operating income: 51263000
Net income: -10087000
Capital expenditures: 19468000
Operating cash flow: 16148000
Depreciation & amortization: 56280000
Net tangible assets: -16825000
Owner earnings: 26725000
Capex to operating income (%): 37.97670834715097
Buffett classification: The Good
Stock price: 2.93
Shares outstanding: 39124686
Book value: -59445000
Market cap (USD): 114635329.98
Debt to equity: -9.222508200857936
Current ratio: 1.90333107955826
Quick ratio: 0.9134910975884607
Interest coverage ratio: 0.9552408459890058
COGS to revenue (%): 66.69944782397893
SG&A to revenue (%): 4.103729789042457
Free cash flow (dilution-adjusted): -11250000
Buyback yield (%): 0
Inventory turnover: 6.189420572323722
Receivables turnover: 11.624259848718212
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.506306284149645
FCF margin (%): -1.1041557477931607
Rule of 40 score: -1.1041557477931607
Financial ratios for MMLP — annual report dated 2023-12-31
Total revenue: 797963000
Gross profit: 358388000
Operating income: 66724000
Net income: -4444000
Capital expenditures: 28835000
Operating cash flow: 137468000
Depreciation & amortization: 49895000
Net tangible assets: -16726000
Owner earnings: 16616000
Capex to operating income (%): 43.21533481206163
Buffett classification: The Good
Stock price: 2.36
Shares outstanding: 39124686
Book value: -64624000
Market cap (USD): 92334258.96
Debt to equity: -7.454784600148551
Current ratio: 1.1367189053736924
Quick ratio: 0.7009566047492144
Effective tax rate (%): 432.2863403944485
Interest coverage ratio: 1.1067175319290097
COGS to revenue (%): 55.08714063183381
SG&A to revenue (%): 5.1162773211289245
Free cash flow (dilution-adjusted): 102988000
Buyback yield (%): 0
Inventory turnover: 10.030920542193419
Receivables turnover: 13.034990280477645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.321478629488933
FCF margin (%): 12.906362826346584
Revenue growth (%): -21.68218373544232
Rule of 40 score: -8.775820909095735
Financial ratios for MMLP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.61
Shares outstanding: 39124686
Market cap (USD): 141240116.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMLP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.55
Shares outstanding: 39124686
Market cap (USD): 138892635.29999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMLP — annual report dated 2024-12-31
Total revenue: 707622000
Gross profit: 359799000
Operating income: 57295000
Net income: -5078000
Capital expenditures: 40766000
Operating cash flow: 48351000
Depreciation & amortization: 50787000
Net tangible assets: -16697000
Owner earnings: 4943000
Capex to operating income (%): 71.15106030194607
Buffett classification: The Good
Stock price: 3.55
Shares outstanding: 39124686
Book value: -70439000
Market cap (USD): 138892635.29999998
Debt to equity: -7.172532261957154
Current ratio: 1.1296785309218103
Quick ratio: 0.6820027532229158
Interest coverage ratio: 1.048878718535469
COGS to revenue (%): 49.15378549564598
SG&A to revenue (%): 6.854224430557558
Free cash flow (dilution-adjusted): 6156000
Buyback yield (%): 0
Inventory turnover: 6.726806815324811
Receivables turnover: 10.520226573301816
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.54466109388002
FCF margin (%): 0.8699559934541323
Revenue growth (%): -11.321452247785926
Rule of 40 score: -10.451496254331794
Financial ratios for MMLP — quarterly report dated 2025-03-31
Total revenue: 192543000
Gross profit: 90151000
Operating income: 13923000
Net income: -1008000
Capital expenditures: 5396000
Operating cash flow: -6019000
Depreciation & amortization: 12816000
Net tangible assets: -16671000
Owner earnings: 6412000
Capex to operating income (%): 38.756015226603466
Buffett classification: The Good
Stock price: 3.57
Shares outstanding: 39124686
Book value: -71628000
Market cap (USD): 139675129.01999998
Debt to equity: -7.266878874183281
Current ratio: 1.3471673801903654
Quick ratio: 0.8856145309447608
Effective tax rate (%): 1329.7619047619048
Interest coverage ratio: 1.0444861215303827
COGS to revenue (%): 53.17877045646946
SG&A to revenue (%): 6.11499768882795
Free cash flow (dilution-adjusted): -11937000
Buyback yield (%): 0
Inventory turnover: 2.305191588995452
Receivables turnover: 2.600351137821595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1847731109352337
FCF margin (%): -6.1996541032392765
Rule of 40 score: -6.1996541032392765
Financial ratios for MMLP — quarterly report dated 2025-06-30
Total revenue: 180676000
Gross profit: 89534000
Operating income: 14270000
Net income: -2349000
Capital expenditures: 4734000
Operating cash flow: 30915000
Depreciation & amortization: 12638000
Net tangible assets: -16671000
Owner earnings: 5555000
Capex to operating income (%): 33.17449194113525
Buffett classification: The Good
Stock price: 2.93
Shares outstanding: 39124686
Book value: -74187000
Market cap (USD): 114635329.98
Debt to equity: -6.644843436181541
Current ratio: 1.1292053970229086
Quick ratio: 0.7008979561515104
Interest coverage ratio: 1.0320387647356621
COGS to revenue (%): 50.44499546148907
SG&A to revenue (%): 6.02293608448272
Free cash flow (dilution-adjusted): 25521000
Buyback yield (%): 0
Inventory turnover: 1.97602116035036
Receivables turnover: 2.724922705678305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.498037716053468
FCF margin (%): 14.125285040625208
Revenue growth (%): -6.16329858784791
Rule of 40 score: 7.961986452777298
Financial ratios for MMLP — quarterly report dated 2025-09-30
Total revenue: 168717000
Gross profit: 80638000
Operating income: 6894000
Net income: -8209000
Capital expenditures: 6279000
Operating cash flow: -1213000
Depreciation & amortization: 12336000
Net tangible assets: -16671000
Owner earnings: -2152000
Capex to operating income (%): 91.07919930374239
Buffett classification: The Gruesome
Stock price: 3.04
Shares outstanding: 39124686
Book value: -82733000
Market cap (USD): 118939045.44
Debt to equity: -6.151173050656933
Current ratio: 1.2018091111179405
Quick ratio: 0.7216673325342922
Interest coverage ratio: 0.5055364083009459
COGS to revenue (%): 52.20517197437129
SG&A to revenue (%): 5.486702584801768
Free cash flow (dilution-adjusted): -7962000
Buyback yield (%): 0
Inventory turnover: 1.879219116705782
Receivables turnover: 2.8775092524687462
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6712524696670343
FCF margin (%): -4.719145077259554
Revenue growth (%): -6.619030751178906
Rule of 40 score: -11.338175828438459
Financial ratios for MMLP — quarterly report dated 2025-12-31
Total revenue: 174177000
Gross profit: 86970000
Operating income: 12718000
Net income: -2823000
Capital expenditures: 6236000
Operating cash flow: 22443000
Depreciation & amortization: 12407000
Net tangible assets: -16672000
Owner earnings: 3348000
Capex to operating income (%): 49.032866802956434
Buffett classification: The Good
Stock price: 2.6
Shares outstanding: 39124686
Book value: -85795000
Market cap (USD): 101724183.60000001
Debt to equity: -5.809872370184743
Current ratio: 1.0464383815438647
Quick ratio: 0.641679353648615
Interest coverage ratio: 0.9272382618839312
COGS to revenue (%): 50.06803424103068
SG&A to revenue (%): 5.793531867008847
Free cash flow (dilution-adjusted): 15550000
Buyback yield (%): 0
Inventory turnover: 1.7355317624582074
Receivables turnover: 2.5875685231678873
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1932709811060196
FCF margin (%): 8.927699983350271
Revenue growth (%): 3.2361884101779905
Rule of 40 score: 12.16388839352826
Financial ratios for MMLP — annual report dated 2025-12-31
Total revenue: 716113000
Gross profit: 347293000
Operating income: 48897000
Net income: -14389000
Capital expenditures: 22645000
Operating cash flow: 46126000
Depreciation & amortization: 50197000
Net tangible assets: -16672000
Owner earnings: 13163000
Capex to operating income (%): 46.31163466061313
Buffett classification: The Good
Stock price: 2.6
Shares outstanding: 39124686
Book value: -85795000
Market cap (USD): 101724183.60000001
Debt to equity: -5.809872370184743
Current ratio: 1.0464383815438647
Quick ratio: 0.641679353648615
Interest coverage ratio: 0.8969951570296448
COGS to revenue (%): 51.503044910509935
SG&A to revenue (%): 5.865554737869582
Free cash flow (dilution-adjusted): 21172000
Buyback yield (%): 0
Inventory turnover: 7.339993631587327
Receivables turnover: 10.63855421686747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.277195405184859
FCF margin (%): 2.9565166391337683
Revenue growth (%): 1.1999344282681996
Rule of 40 score: 4.156451067401968
Financial ratios for NEM.AX — annual report dated 2023-12-31
Total revenue: 11812000000
Gross profit: 3005000000
Operating income: 708000000
Net income: -2467000000
Capital expenditures: 2666000000
Operating cash flow: 2763000000
Depreciation & amortization: 2108000000
Net tangible assets: 26026000000
Owner earnings: -3025000000
Return on net tangible assets (%): -11.62299239222316
Capex to operating income (%): 376.55367231638417
Buffett classification: The Gruesome
Stock price: 40.342465753424655
Shares outstanding: 1053692271
Book value: 29205000000
P/B ratio: 1.4555228336745678
Market cap (USD): 42508544357.46575
Debt to equity: 0.32309536038349596
Current ratio: 1.2524174724908304
Quick ratio: 0.8119373124374791
Interest coverage ratio: 2.9135802469135803
COGS to revenue (%): 74.55976972570268
R&D to revenue (%): 1.6931933626820181
SG&A to revenue (%): 2.531324077209617
Free cash flow (dilution-adjusted): 17000000
Buyback yield (%): 0
Retained earnings: -2996000000
Inventory turnover: 3.3334595003785013
Receivables turnover: 16.092643051771116
Capitalized R&D asset: 353430000
ROCI (R&D-adjusted, %): 1.5342520260650365
Rosenberg metric: -1.1222707423580787
FCF margin (%): 0.14392143582797157
Revenue growth (%): -0.8644565673520772
Rule of 40 score: -0.7205351315241056
Financial ratios for NEM.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.78620689655173
Shares outstanding: 1053692271
Market cap (USD): 55620418222.30346
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEM.AX — annual report dated 2024-12-31
Total revenue: 18682000000
Gross profit: 7143000000
Operating income: 5910000000
Net income: 3381000000
Capital expenditures: 2842000000
Operating cash flow: 6363000000
Depreciation & amortization: 2576000000
Net tangible assets: 27270000000
Owner earnings: 3115000000
Return on net tangible assets (%): 11.422808947561423
Capex to operating income (%): 48.08798646362098
Buffett classification: The Good
Stock price: 36.46583850931677
P/E ratio: 11.364617625791553
Shares outstanding: 1053692271
Book value: 30109000000
P/B ratio: 1.2761557073566454
Market cap (USD): 38423772192.80124
Debt to equity: 0.2979839914975589
Current ratio: 1.6273366034734191
Quick ratio: 1.3377966326395334
Effective tax rate (%): 30.52217609788071
Interest coverage ratio: 15.76
COGS to revenue (%): 61.765335617171615
R&D to revenue (%): 1.05449095385933
SG&A to revenue (%): 2.365913713735146
Free cash flow (dilution-adjusted): 2872000000
Buyback yield (%): 3.242784164313363
Retained earnings: -1320000000
Inventory turnover: 5.283424908424909
Receivables turnover: 12.037371134020619
Capitalized R&D asset: 406570000
ROCI (R&D-adjusted, %): 11.985420256112073
Rosenberg metric: 20.69
FCF margin (%): 15.373086393319774
Revenue growth (%): 58.16119200812733
Rule of 40 score: 73.5342784014471
Financial ratios for NEM.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.46583850931677
Shares outstanding: 1053692271
Market cap (USD): 38423772192.80124
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEM.AX — quarterly report dated 2025-03-31
Total revenue: 5010000000
Gross profit: 2311000000
Operating income: 2016000000
Net income: 1902000000
Capital expenditures: 858000000
Operating cash flow: 2031000000
Depreciation & amortization: 593000000
Net tangible assets: 28590000000
Owner earnings: 1637000000
Return on net tangible assets (%): 5.725778244141308
Capex to operating income (%): 42.55952380952381
Buffett classification: The Good
Stock price: 47.99999999999999
P/E ratio: 6.647900763406939
Shares outstanding: 1053692271
Book value: 31431000000
P/B ratio: 1.6091511249403452
Market cap (USD): 50577229007.99999
Debt to equity: 0.2540803665171328
Current ratio: 1.979358643568006
Quick ratio: 1.5582381127902691
Effective tax rate (%): 26.18373128288142
Interest coverage ratio: 25.518987341772153
COGS to revenue (%): 53.87225548902196
R&D to revenue (%): 0.8582834331337325
SG&A to revenue (%): 2.19560878243513
Free cash flow (dilution-adjusted): 1184000000
Buyback yield (%): 0.6880566745658516
Retained earnings: 153000000
Inventory turnover: 1.1811816192560176
Receivables turnover: 5.648252536640361
Capitalized R&D asset: 43000000
ROCI (R&D-adjusted, %): 4.078240519121323
FCF margin (%): 23.632734530938123
Rule of 40 score: 23.632734530938123
Financial ratios for NEM.AX — quarterly report dated 2025-06-30
Total revenue: 5317000000
Gross profit: 2696000000
Operating income: 2417000000
Net income: 2075000000
Capital expenditures: 317000000
Operating cash flow: 2384000000
Depreciation & amortization: 620000000
Net tangible assets: 29454000000
Owner earnings: 2378000000
Return on net tangible assets (%): 8.073606301351258
Capex to operating income (%): 13.115432354158047
Buffett classification: The Great
Stock price: 56.653594771241835
P/E ratio: 15.010172223993848
Shares outstanding: 1053692271
Book value: 32287000000
P/B ratio: 1.8489006391062512
Market cap (USD): 59695454934.82353
Debt to equity: 0.23560566172143588
Current ratio: 2.2267665952890794
Quick ratio: 1.7413276231263384
Effective tax rate (%): 35.02245028864657
Interest coverage ratio: 37.184615384615384
COGS to revenue (%): 49.29471506488621
R&D to revenue (%): 0.7523039307880384
SG&A to revenue (%): 1.7867218356215913
Free cash flow (dilution-adjusted): 1683000000
Buyback yield (%): 1.6935962731230145
Retained earnings: 1449000000
Inventory turnover: 1.1561535068372297
Receivables turnover: 8.346938775510203
Capitalized R&D asset: 68810000
ROCI (R&D-adjusted, %): 4.804490273445244
Rosenberg metric: 8.953488372093023
FCF margin (%): 31.653187887906714
Revenue growth (%): 6.127744510978044
Rule of 40 score: 37.78093239888476
Financial ratios for NEM.AX — quarterly report dated 2025-09-30
Total revenue: 5524000000
Gross profit: 2930000000
Operating income: 2616000000
Net income: 1843000000
Capital expenditures: 613000000
Operating cash flow: 2298000000
Depreciation & amortization: 643000000
Net tangible assets: 30568000000
Owner earnings: 1873000000
Return on net tangible assets (%): 6.127322690395184
Capex to operating income (%): 23.432721712538225
Buffett classification: The Great
Stock price: 84.58552631578947
P/E ratio: 15.313937339761937
Shares outstanding: 1053692271
Book value: 33411000000
P/B ratio: 2.6675979562842915
Market cap (USD): 89127115317.41446
Debt to equity: 0.16913591332195985
Current ratio: 2.0393236335037357
Quick ratio: 1.5580023594180101
Effective tax rate (%): 31.392102114080572
Interest coverage ratio: 50.30769230769231
COGS to revenue (%): 46.95872556118755
R&D to revenue (%): 0.724112961622013
SG&A to revenue (%): 1.556842867487328
Free cash flow (dilution-adjusted): 1548000000
Buyback yield (%): 0.5789483909159789
Retained earnings: 2699000000
Inventory turnover: 1.059640522875817
Receivables turnover: 5.2760267430754535
Capitalized R&D asset: 80990000
ROCI (R&D-adjusted, %): 5.2631589540422565
Rosenberg metric: 5.85
FCF margin (%): 28.023171614771904
Revenue growth (%): 3.8931728418280986
Rule of 40 score: 31.9163444566
Financial ratios for NEM.AX — annual report dated 2025-12-31
Total revenue: 22669000000
Gross profit: 12063000000
Operating income: 11023000000
Net income: 7167000000
Capital expenditures: 224000000
Operating cash flow: 10334000000
Depreciation & amortization: 2521000000
Net tangible assets: 31209000000
Owner earnings: 9464000000
Return on net tangible assets (%): 30.324585856643914
Capex to operating income (%): 2.032114669327769
Buffett classification: The Great
Stock price: 100.48993288590603
P/E ratio: 14.774028965423177
Shares outstanding: 1053692271
Book value: 34042000000
P/B ratio: 3.1104360964452122
Market cap (USD): 105885465595.18791
Debt to equity: 0.16417954291757242
Current ratio: 2.2874649859943976
Quick ratio: 1.816701680672269
Effective tax rate (%): 40.52195380003526
Interest coverage ratio: 48.1353711790393
COGS to revenue (%): 46.786360227623625
R&D to revenue (%): 0.7322775596629759
SG&A to revenue (%): 1.6851206493449202
Free cash flow (dilution-adjusted): 7200000000
Buyback yield (%): 2.1749916167008503
Retained earnings: 3431000000
Inventory turnover: 3.9442171811082187
Receivables turnover: 12.99083094555874
Capitalized R&D asset: 363990000
ROCI (R&D-adjusted, %): 21.249175165145637
Rosenberg metric: 24.9746192893401
FCF margin (%): 31.761436322731484
Revenue growth (%): 21.341398137244404
Rule of 40 score: 53.10283445997589
Financial ratios for NEM.AX — quarterly report dated 2025-12-31
Total revenue: 6818000000
Gross profit: 4126000000
Operating income: 3974000000
Net income: 1347000000
Capital expenditures: 786000000
Operating cash flow: 3621000000
Depreciation & amortization: 665000000
Net tangible assets: 31209000000
Owner earnings: 1226000000
Return on net tangible assets (%): 3.9283540004485884
Capex to operating income (%): 19.77856064418722
Buffett classification: The Great
Stock price: 100.48993288590603
P/E ratio: 14.774028965423177
Shares outstanding: 1053692271
Book value: 34042000000
P/B ratio: 3.1104360964452122
Market cap (USD): 105885465595.18791
Debt to equity: 0.16417954291757242
Current ratio: 2.2874649859943976
Quick ratio: 1.816701680672269
Effective tax rate (%): 63.77079482439926
Interest coverage ratio: 120.42424242424242
COGS to revenue (%): 39.48371956585509
R&D to revenue (%): 0.6306834848929305
SG&A to revenue (%): 1.3347022587268993
Free cash flow (dilution-adjusted): 2785000000
Buyback yield (%): 0.40421033953450447
Retained earnings: 3431000000
Inventory turnover: 1.0011156563778356
Receivables turnover: 3.907163323782235
Capitalized R&D asset: 83000000
ROCI (R&D-adjusted, %): 7.721587819467102
Rosenberg metric: 29.9
FCF margin (%): 40.8477559401584
Revenue growth (%): 23.42505430847212
Rule of 40 score: 64.27281024863052
Financial ratios for NOVT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 176.33
Shares outstanding: 35613303
Market cap (USD): 6279693717.990001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVT — annual report dated 2022-12-31
Total revenue: 860903000
Gross profit: 378472000
Operating income: 107463000
Net income: 74051000
Capital expenditures: 20976000
Operating cash flow: 90779000
Depreciation & amortization: 53158000
Net tangible assets: -77077000
Owner earnings: 106233000
Return on net tangible assets (%): -137.82710795697807
Capex to operating income (%): 19.519276402110496
Buffett classification: The Great
Stock price: 135.87
P/E ratio: 65.34387757910089
Shares outstanding: 35613303
Book value: 577586000
P/B ratio: 8.377591351954514
Market cap (USD): 4838779478.610001
Debt to equity: 0.8472902736562175
Current ratio: 2.556004668068708
Quick ratio: 1.534882872807284
Effective tax rate (%): 15.039181266421139
COGS to revenue (%): 56.03778822933594
R&D to revenue (%): 9.962794879330191
SG&A to revenue (%): 18.45748011099973
Free cash flow (dilution-adjusted): 46558000
Buyback yield (%): 0.2066636854232635
Retained earnings: 130584000
Inventory turnover: 2.8716643749590767
Receivables turnover: 6.184425846772745
Capitalized R&D asset: 85770000
ROCI (R&D-adjusted, %): 14.163326049928598
FCF margin (%): 5.408042485622654
Rule of 40 score: 5.408042485622654
Financial ratios for NOVT — annual report dated 2023-12-31
Total revenue: 881662000
Gross profit: 399897000
Operating income: 123310000
Net income: 72878000
Capital expenditures: 19892000
Operating cash flow: 120075000
Depreciation & amortization: 46612000
Net tangible assets: 43931000
Owner earnings: 99598000
Return on net tangible assets (%): 226.71462065511827
Capex to operating income (%): 16.13170059200389
Buffett classification: The Great
Stock price: 168.41
P/E ratio: 82.29693951851038
Shares outstanding: 35613303
Book value: 673460000
P/B ratio: 8.90570539932587
Market cap (USD): 5997636358.23
Debt to equity: 0.600715706946218
Current ratio: 2.983991377761811
Quick ratio: 1.9107310939464703
Effective tax rate (%): 12.979414433777523
COGS to revenue (%): 54.642822306053795
R&D to revenue (%): 10.398769596512041
SG&A to revenue (%): 18.653406861132723
Free cash flow (dilution-adjusted): 74526000
Buyback yield (%): 0
Retained earnings: 203462000
Inventory turnover: 3.2252913885560117
Receivables turnover: 5.976761685252347
Capitalized R&D asset: 149147900
ROCI (R&D-adjusted, %): 12.608227310326914
Rosenberg metric: 0.24979596595546227
FCF margin (%): 8.452899183587363
Revenue growth (%): 2.411305338696694
Rule of 40 score: 10.864204522284057
Financial ratios for NOVT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 178.92
Shares outstanding: 35613303
Market cap (USD): 6371932172.759999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 152.77
Shares outstanding: 35613303
Market cap (USD): 5440644299.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVT — annual report dated 2024-12-31
Total revenue: 949245000
Gross profit: 421545000
Operating income: 124293000
Net income: 64087000
Capital expenditures: 16989000
Operating cash flow: 158512000
Depreciation & amortization: 55563000
Net tangible assets: -24244000
Owner earnings: 102661000
Return on net tangible assets (%): -423.44910080844744
Capex to operating income (%): 13.668509087398325
Buffett classification: The Great
Stock price: 152.77
P/E ratio: 84.89466349353224
Shares outstanding: 35613303
Book value: 745698000
P/B ratio: 7.296042498853424
Market cap (USD): 5440644299.31
Debt to equity: 0.6306064921724344
Current ratio: 2.5844532781853617
Quick ratio: 1.7226311303943596
Effective tax rate (%): 18.944932082058028
COGS to revenue (%): 55.591549073210814
R&D to revenue (%): 10.062207333196383
SG&A to revenue (%): 18.535046273617453
Free cash flow (dilution-adjusted): 118043000
Buyback yield (%): 0
Retained earnings: 267549000
Inventory turnover: 3.6492261731878344
Receivables turnover: 5.966266923105932
Capitalized R&D asset: 185246040
ROCI (R&D-adjusted, %): 9.162312341484435
Rosenberg metric: 0.236120503479418
FCF margin (%): 12.43546186706277
Revenue growth (%): 7.665409193092137
Rule of 40 score: 20.10087106015491
Financial ratios for NOVT — quarterly report dated 2025-03-31
Total revenue: 233366000
Gross profit: 104354000
Operating income: 29966000
Net income: 21208000
Capital expenditures: 1253000
Operating cash flow: 31684000
Depreciation & amortization: 13563000
Net tangible assets: 2977000
Owner earnings: 33518000
Return on net tangible assets (%): 1125.8985555928787
Capex to operating income (%): 4.181405593005406
Buffett classification: The Great
Stock price: 127.87
P/E ratio: 53.681076181275934
Shares outstanding: 35613303
Book value: 769755000
P/B ratio: 5.916003214802113
Market cap (USD): 4553873054.610001
Debt to equity: 0.5748985066677059
Current ratio: 2.9596416835962533
Quick ratio: 1.9681701048498152
Effective tax rate (%): 19.72140207434325
COGS to revenue (%): 55.28311750640624
R&D to revenue (%): 9.957748772314732
SG&A to revenue (%): 19.538407480095643
Free cash flow (dilution-adjusted): 20300000
Buyback yield (%): 0.13520359320879868
Retained earnings: 288757000
Inventory turnover: 0.8870767009316877
Receivables turnover: 1.372490898718469
Capitalized R&D asset: 23238000
ROCI (R&D-adjusted, %): 3.602037388035575
FCF margin (%): 8.69878217049613
Rule of 40 score: 8.69878217049613
Financial ratios for NOVT — quarterly report dated 2025-06-30
Total revenue: 241049000
Gross profit: 106746000
Operating income: 27483000
Net income: 4497000
Capital expenditures: 3388000
Operating cash flow: 15072000
Depreciation & amortization: 15581000
Net tangible assets: -51277000
Owner earnings: 16690000
Return on net tangible assets (%): -32.548706047545686
Capex to operating income (%): 12.327620710984972
Buffett classification: The Great
Stock price: 128.93
P/E ratio: 178.62762714608053
Shares outstanding: 35613303
Book value: 801446000
P/B ratio: 5.7291734637018585
Market cap (USD): 4591623155.79
Debt to equity: 0.6406008639384313
Current ratio: 2.5398762215699855
Quick ratio: 1.6161274719959546
Effective tax rate (%): 22.318189670063916
COGS to revenue (%): 55.716057731000745
R&D to revenue (%): 10.491227924612838
SG&A to revenue (%): 19.540840244099748
Free cash flow (dilution-adjusted): 4186000
Buyback yield (%): 0
Retained earnings: 293254000
Inventory turnover: 0.7991134382530568
Receivables turnover: 1.4232767681061866
Capitalized R&D asset: 40858460
ROCI (R&D-adjusted, %): 2.6712857581643976
Rosenberg metric: 0.10293484809363973
FCF margin (%): 1.736576380735867
Revenue growth (%): 3.292253370242452
Rule of 40 score: 5.028829750978319
Financial ratios for NOVT — quarterly report dated 2025-09-30
Total revenue: 247836000
Gross profit: 110921000
Operating income: 28525000
Net income: 10653000
Capital expenditures: 4283000
Operating cash flow: 8495000
Depreciation & amortization: 15711000
Net tangible assets: -39285000
Owner earnings: 22081000
Return on net tangible assets (%): -56.20720376734123
Capex to operating income (%): 15.01489921121823
Buffett classification: The Great
Stock price: 100.15
P/E ratio: 98.09869342235547
Shares outstanding: 35613303
Book value: 801476000
P/B ratio: 4.450129879684482
Market cap (USD): 3566672295.4500003
Debt to equity: 0.6294386856250218
Current ratio: 2.5067911805629883
Quick ratio: 1.5436262442470299
Effective tax rate (%): 32.39624317806828
COGS to revenue (%): 55.244193741022286
R&D to revenue (%): 9.720137510289062
SG&A to revenue (%): 20.73064445843219
Free cash flow (dilution-adjusted): -2486000
Buyback yield (%): 0.39409283600097555
Retained earnings: 303907000
Inventory turnover: 0.7607360940564628
Receivables turnover: 1.374438491997471
Capitalized R&D asset: 48702170
ROCI (R&D-adjusted, %): 2.077232295182947
Rosenberg metric: 0.1650915417770572
FCF margin (%): -1.0030826837101956
Revenue growth (%): 2.8156101041696915
Rule of 40 score: 1.8125274204594959
Financial ratios for NOVT — annual report dated 2025-12-31
Total revenue: 980600000
Gross profit: 435284000
Operating income: 116664000
Net income: 53829000
Capital expenditures: 10031000
Operating cash flow: 64056000
Depreciation & amortization: 61932000
Net tangible assets: 486163000
Owner earnings: 105730000
Return on net tangible assets (%): 21.747850000925613
Capex to operating income (%): 8.598196530206405
Buffett classification: The Great
Stock price: 118.99
P/E ratio: 78.72386490497686
Shares outstanding: 35613303
Book value: 1314287000
P/B ratio: 3.2242782010093687
Market cap (USD): 4237626923.97
Debt to equity: 0.2297116231081948
Current ratio: 3.6851346960685984
Quick ratio: 2.7985374375491485
Effective tax rate (%): 22.706125613853708
COGS to revenue (%): 55.61044258617173
R&D to revenue (%): 9.737303691617377
SG&A to revenue (%): 19.952987966551092
Free cash flow (dilution-adjusted): 18891000
Buyback yield (%): 0.9268866916486975
Retained earnings: 321378000
Inventory turnover: 2.8962418474219795
Receivables turnover: 5.047822013569303
Capitalized R&D asset: 189734110
ROCI (R&D-adjusted, %): 6.608169063416147
Rosenberg metric: 0.143841281474114
FCF margin (%): 1.926473587599429
Revenue growth (%): 3.303151451943387
Rule of 40 score: 5.229625039542816
Financial ratios for NOVT — quarterly report dated 2025-12-31
Total revenue: 258349000
Gross profit: 113263000
Operating income: 30690000
Net income: 17471000
Capital expenditures: 3613000
Operating cash flow: 8805000
Depreciation & amortization: 17077000
Net tangible assets: 486163000
Owner earnings: 30935000
Return on net tangible assets (%): 6.363092213928251
Capex to operating income (%): 11.772564353209516
Buffett classification: The Great
Stock price: 118.99
P/E ratio: 78.72386490497686
Shares outstanding: 35613303
Book value: 1314287000
P/B ratio: 3.2242782010093687
Market cap (USD): 4237626923.97
Debt to equity: 0.2297116231081948
Current ratio: 3.6851346960685984
Quick ratio: 2.7985374375491485
Effective tax rate (%): 19.403053928126585
COGS to revenue (%): 56.15891681407709
R&D to revenue (%): 8.851205152719771
SG&A to revenue (%): 19.96601496425378
Free cash flow (dilution-adjusted): -3109000
Buyback yield (%): 0.44989802882739494
Retained earnings: 321378000
Inventory turnover: 0.7705699900150836
Receivables turnover: 1.3298998260081745
Capitalized R&D asset: 47352670
ROCI (R&D-adjusted, %): 1.7949667816048298
Rosenberg metric: 0.09721876297218764
FCF margin (%): -1.2034108899202243
Revenue growth (%): 4.241918042576542
Rule of 40 score: 3.038507152656318
Financial ratios for NVU.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.021739130434782608
Shares outstanding: 1087314827
Market cap (USD): 23637278.847826086
Buyback yield (%): 0.41704265904089133
Capitalized R&D asset: 77326.08695652174
Rule of 40 score: 0
Financial ratios for NVU.AX — annual report dated 2022-12-31
Total revenue: 107778.37837837837
Gross profit: 48899.32432432433
Operating income: -1227245.945945946
Net income: -1829257.4324324324
Capital expenditures: 0
Depreciation & amortization: 30416.216216216217
Net tangible assets: -184738.51351351352
Owner earnings: -1798841.216216216
Buffett classification: The Gruesome
Stock price: 0.006756756756756757
Shares outstanding: 1087314827
Book value: -184738.5135135135
Market cap (USD): 7346721.804054054
Debt to equity: -1.0972411699516849
Current ratio: 0.5204946164439276
Quick ratio: 0.5204946164439276
Interest coverage ratio: -10.30269546671507
COGS to revenue (%): 54.629745724459596
R&D to revenue (%): 5.9782336125181805
SG&A to revenue (%): 1071.6554240433322
Free cash flow (dilution-adjusted): -1288751.3513513515
Buyback yield (%): 0.062097929986197085
Retained earnings: -11470709.45945946
Receivables turnover: 1.5220320222896508
Capitalized R&D asset: 58251.72150411281
FCF margin (%): -1195.7420131400775
Rule of 40 score: -1195.7420131400775
Financial ratios for NVU.AX — annual report dated 2023-12-31
Total revenue: 70230.82191780822
Gross profit: 17305.479452054795
Operating income: -1488247.9452054794
Net income: -1479389.0410958903
Capital expenditures: 0
Depreciation & amortization: 115496.57534246576
Net tangible assets: -89126.71232876713
Owner earnings: -1363892.4657534247
Buffett classification: The Gruesome
Stock price: 0.013698630136986302
Shares outstanding: 1087314827
Book value: -74938.35616438359
Market cap (USD): 14894723.657534247
Debt to equity: -2.0588794442921117
Current ratio: 0.557963891186919
Quick ratio: 0.557963891186919
Interest coverage ratio: -148.32698477711787
COGS to revenue (%): 75.35913865238889
R&D to revenue (%): 15.966919258414036
SG&A to revenue (%): 1505.5648205038183
Free cash flow (dilution-adjusted): -1373945.890410959
Buyback yield (%): 0
Retained earnings: -12711880.821917808
Receivables turnover: 2.647687659772252
Capitalized R&D asset: 41048.28029876214
Rosenberg metric: -4.903407132021697
FCF margin (%): -1956.328934921053
Revenue growth (%): -34.83774484781323
Rule of 40 score: -1991.166679768866
Financial ratios for NVU.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 232885.09316770185
Buffett classification: The Gruesome
Stock price: 0.018633540372670804
Shares outstanding: 1087314827
Book value: 210116.77018633543
P/B ratio: 96.42507215745161
Market cap (USD): 20260524.72670807
Debt to equity: 0.3734480679184599
Current ratio: 1.0104871571721379
Quick ratio: 1.0104871571721379
Buyback yield (%): 0
Retained earnings: -13272705.590062112
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NVU.AX — annual report dated 2024-12-31
Total revenue: 4268.944099378882
Gross profit: 6540.372670807453
Operating income: -1749073.9130434783
Net income: -1745161.4906832296
Capital expenditures: 0
Depreciation & amortization: 66780.74534161491
Net tangible assets: 232885.09316770185
Owner earnings: -1678380.7453416148
Return on net tangible assets (%): -720.6905012735201
Buffett classification: The Gruesome
Stock price: 0.018633540372670804
Shares outstanding: 1087314827
Book value: 210116.77018633543
P/B ratio: 96.42507215745161
Market cap (USD): 20260524.72670807
Debt to equity: 0.3734480679184599
Current ratio: 1.0104871571721379
Quick ratio: 1.0104871571721379
Interest coverage ratio: -492.65377886634013
COGS to revenue (%): -53.20820602357048
SG&A to revenue (%): 28773.708715262615
Free cash flow (dilution-adjusted): -1144403.7267080746
Buyback yield (%): 0
Retained earnings: -13272705.590062112
Receivables turnover: 0.5455194856734662
Capitalized R&D asset: 9639.448352462052
ROCI (R&D-adjusted, %): -798.5938109072307
Rosenberg metric: -0.9599960848168285
FCF margin (%): -26807.65313545759
Revenue growth (%): -93.92155184460908
Rule of 40 score: -26901.5746873022
Financial ratios for NZF — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.5
Shares outstanding: 196386986
Market cap (USD): 2454837325
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NZF — annual report dated 2022-10-31
Total revenue: -612325596
Net income: -615761175
Capital expenditures: 0
Operating cash flow: 73630312
Net tangible assets: 2025136489
Owner earnings: -615761175
Return on net tangible assets (%): -30.40590984087493
Buffett classification: The Gruesome
Stock price: 8.52
Shares outstanding: 196386986
Book value: 2025136489
P/B ratio: 0.8262243704601977
Market cap (USD): 1673217120.72
Debt to equity: 0.021156720661903
Free cash flow (dilution-adjusted): 73630312
Buyback yield (%): 0
Retained earnings: -329487579
Receivables turnover: -3.803823213663895
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NZF — annual report dated 2023-10-31
Total revenue: -1159561
Net income: -4078093
Capital expenditures: 0
Operating cash flow: -11664650
Net tangible assets: 2316713489
Owner earnings: -4078093
Return on net tangible assets (%): -0.1760292336261353
Buffett classification: The Gruesome
Stock price: 8.32
Shares outstanding: 196386986
Book value: 2316713489
P/B ratio: 0.7052834678427515
Market cap (USD): 1633939723.52
Debt to equity: 0
Free cash flow (dilution-adjusted): -11664650
Buyback yield (%): 3.0732361957528083
Retained earnings: -450153154
Receivables turnover: -0.016245218472544218
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NZF — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 2617134801
Buffett classification: The Gruesome
Stock price: 11.15
Shares outstanding: 196386986
Book value: 2617134801
P/B ratio: 0.8366840305907498
Market cap (USD): 2189714893.9
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -117906961
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NZF — annual report dated 2024-10-31
Total revenue: 30152284.5
Net income: 450755056
Capital expenditures: 0
Operating cash flow: 198645126
Net tangible assets: 2617134801
Owner earnings: 450755056
Return on net tangible assets (%): 17.223226554007372
Buffett classification: The Gruesome
Stock price: 11.15
P/E ratio: 4.857882046474483
Shares outstanding: 196386986
Book value: 2617134801
P/B ratio: 0.8366840305907498
Market cap (USD): 2189714893.9
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 9.81686478847067
Free cash flow (dilution-adjusted): 198645126
Buyback yield (%): 0
Retained earnings: -117906961
Receivables turnover: 0.18950981616640242
Capitalized R&D asset: 0
FCF margin (%): 658.8062208022745
Rule of 40 score: 658.8062208022745
Financial ratios for NZF — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 2440285001
Buffett classification: The Gruesome
Stock price: 10.88
Shares outstanding: 196386986
Book value: 2440285001
P/B ratio: 0.8755905178306672
Market cap (USD): 2136690407.68
Debt to equity: 0.002269301740465027
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OGI — annual report dated 2021-08-31
Total revenue: 87029365.07936507
Gross profit: -22538888.888888888
Operating income: -57808730.15873016
Net income: -103733333.33333333
Capital expenditures: 9330952.38095238
Operating cash flow: -22689682.53968254
Depreciation & amortization: 24629365.07936508
Net tangible assets: 367269047.61904764
Owner earnings: -88434920.63492063
Return on net tangible assets (%): -24.07905626902988
Buffett classification: The Gruesome
Stock price: 10.68
Shares outstanding: 140775022
Book value: 380797619.04761904
P/B ratio: 3.948231710902554
Market cap (USD): 1503477234.96
Debt to equity: 0.0123904502870958
Current ratio: 9.922142693977005
Quick ratio: 8.063542221883804
Interest coverage ratio: -24.60777027027027
COGS to revenue (%): 98.08949725051754
R&D to revenue (%): 3.3240012037535225
SG&A to revenue (%): 42.378507528019185
Free cash flow (dilution-adjusted): -35539682.53968254
Buyback yield (%): 0
Retained earnings: -218765079.36507937
Inventory turnover: 2.203326641812446
Receivables turnover: 5.151844021611463
Capitalized R&D asset: 2892857.1428571427
ROCI (R&D-adjusted, %): -13.249817461930464
FCF margin (%): -40.836426311133806
Rule of 40 score: -40.836426311133806